TOPICS: Glycoprotein IIb/IIIa inhibitors, fibrinogen, platelet aggregation, thrombus formation, abciximab, monoclonal ab, eptifibatide, tirofiban, unstable angina, percutaneous coronary intervention, bleeding, thrombocytopenia, active bleed, bleeding, surgery, trauma, platelet count < 100,000/mm³
